United States
Hong KongDSCSA transaction information at pharmacy receipt
When a dispenser accepts ownership of a covered prescription drug in a DSCSA transaction, the previous owner must provide the required product-tracing information and transaction statement.
More key points
- Under enhanced drug-distribution security requirements, trading partners generally exchange transaction information with package-level product identifiers and transaction statements through secure, interoperable electronic systems; transaction history is no longer the routine required record.
On this page5 sections
A pharmacy receives a shipment. The package barcode identifies the drug package, but that barcode is not the entire transaction record. The DSCSA also requires tracing information to follow covered changes of ownership so an authorized trading partner can investigate a suspect product or respond to a recall.
| Record or identifier | What it tells the dispenser | Exam distinction |
|---|---|---|
| Transaction information (TI) | Information about the transaction and the product transferred, including required product-level details. | It describes a particular transfer; it is not just the product’s printed NDC. |
| Transaction statement (TS) | The transferring trading partner’s statement that it meets the applicable statutory conditions for the transaction. | It is a compliance attestation, not a second package barcode. |
| Transaction history (TH) | Older record tracing prior sales, purchases, and trades. | Beginning with enhanced tracing, the statute generally no longer requires routine exchange of TH for covered transactions. |
| Product identifier (PI) | Package-level NDC, serial number, lot number, and expiration date in human- and machine-readable form. | The PI is associated with the product and supports tracing; it is not the TI or TS itself. |
What changes hands with the drug
The DSCSA generally prohibits a dispenser from accepting ownership of a covered product unless the previous owner provides the required tracing information and statement before or at the transaction. The tracing obligations are tied to the regulated transaction and authorized trading partners; exclusions, exceptions, and waivers can change the result for a particular transfer.
The original law described three records: transaction history, transaction information, and a transaction statement. Enhanced drug-distribution security changed the routine exchange model. For covered transactions, trading partners generally use secure, interoperable electronic exchange of transaction information containing package-level identifiers and transaction statements. The statute ended routine transaction-history exchange for this enhanced system.
What the pharmacy should match on receipt
- Confirm the supplier is an authorized trading partner under the applicable DSCSA rules.
- Receive and retain the transaction information and transaction statement through the trading partners’ compliant exchange process.
- Check that the received product and package identifiers align with the shipment and associated records.
- Follow pharmacy procedures for discrepancies, missing data, verification alerts, and suspect product; do not simply dispense and investigate later.
- Make sure the required records remain accessible for an investigation or regulator request.
Do not confuse receipt documentation with package scanning
Scanning a 2D data-matrix barcode reads the product identifier’s package data. It can support verification, inventory, and tracing, but scanning by itself does not supply the full transaction information or the seller’s transaction statement. A pharmacy needs the interoperable transaction record as well as a process to read or verify package-level information when required.
Likewise, an invoice or packing slip is not automatically a DSCSA transaction statement. A document’s title does not determine whether it meets the statute. The required records and exchange must satisfy the applicable DSCSA requirements and FDA guidance.
Retention, investigation, and suspect product
A dispenser must keep required product-tracing records for the statutory retention period and be able to use them when investigating a suspect product. The records help trace ownership back through the supply chain. If a product appears counterfeit, diverted, stolen, or otherwise illegitimate, the pharmacy should quarantine or otherwise appropriately handle it and follow the verification, investigation, notification, and disposition procedures that apply.
Older materials may say “transaction history, transaction information, and transaction statement” as a three-part routine exchange. Under enhanced tracing, transaction history is not the routine required exchange for covered transactions. Read the item’s date and use current FDA guidance when interpreting an up-to-date question.
A quick way to answer a DSCSA receipt question
- Ask whether the pharmacy is accepting ownership in a covered transaction or dispensing to a patient.
- Identify the supplier and whether it is an authorized trading partner.
- Separate product identifier data from transaction information and the transaction statement.
- Apply enhanced electronic tracing requirements and any stated exception or waiver.
- If required documentation or package data are missing or inconsistent, follow the investigation and escalation process before the product enters dispensing stock.
Common questions
What DSCSA information must a pharmacy receive when it accepts product?
For a covered transaction, the previous owner provides the required transaction information and transaction statement before or at the transfer. Enhanced requirements generally use secure, interoperable electronic exchange with package-level identifiers; exceptions and waivers can apply.
Is a product identifier the same as transaction information?
No. The product identifier is package data such as the NDC, serial number, lot number, and expiration date. Transaction information describes the transfer, and a transaction statement is the trading partner’s statutory compliance statement.
Does a pharmacy still routinely receive transaction history?
Under enhanced drug-distribution security requirements, routine transaction-history exchange is generally no longer required for covered transactions. The pharmacy still needs the required transaction information, transaction statement, package-level data, and records needed for verification and investigations.
Does the DSCSA tracing requirement apply when a pharmacy dispenses a prescription to a patient?
The law distinguishes a covered ownership transaction from dispensing to an individual patient, and some specific patient-need transfers between pharmacies also have an exception. Check the statutory transaction definition and FDA guidance for the exact circumstance.